SGLT2 Inhibitor Use and the Risk of Clinical Events in Patients With Cancer Therapy–Related Cardiac Dysfunction
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JACC: Heart Failure
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy-Related Cardiac Dysfunction
JACC Heart Fail 2023 Oct 12;[EPub Ahead of Print], V Avula, G Sharma, MN Kosiborod, M Vaduganathan, TG Neilan, T Lopez, S Dent, L Baldassarre, M Scherrer-Crosbie, A Barac, J Liu, A Deswal, S Khadke, EH Yang, B Ky, D Lenihan, A Nohria, SS Dani, S GanatraFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.